Document is current
Any future updates will be listed below
-
Authors
Ahmed, Taqwa
Kayal, Maia
Hashem, Dana
Ungaro, Ryan C.
- License Information
-
More Information
Article History
Accepted: 16 November 2022
First Online: 7 March 2023
Declarations
:
: MK has served as a consultant for GoodRx and Abbvie. RCU has served as a consultant for AbbVie, Bristol Myers Squibb, Janssen, Pfizer, and Takeda and has received research grants from AbbVie, Boehringer Ingelheim, Bristol Myers Squibb, and Pfizer. RCU supported by an NIH K23 Career Development Award (5K23DK111995).
